Article Information
History
- August 4, 2021.
Article Versions
- You are currently viewing Version 1 of this article (August 4, 2021 - 09:19).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Marie Suehiro1,
- Shinya Okubo2,
- Kensuke Nakajima2,
- Kosuke Kanda3,
- Masanobu Hayakawa3,
- Shigeru Oiso2,
- Tsutomu Kabashima4,
- Hideaki Fujita5,
- Yukio Ando6 and
- Takahiro Muro1,*
- 1Division of Medical Informatics, Faculty of Pharmaceutical Sciences, Nagasaki International University
- 2Division of Pharmaceutical Health Care and Science, Faculty of Pharmaceutical Sciences, Nagasaki International University
- 3Division of Clinical pharmaceutics, Faculty of Pharmaceutical Sciences, Nagasaki International University
- 4Division of Pharmaceutical Technology, Faculty of Pharmaceutical Sciences, Nagasaki International University
- 5Section of Functional Morphology, Faculty of Pharmaceutical Sciences, Nagasaki International University
- 6Division of Amyloidosis Research, Department of Pharmacy, Faculty of Pharmaceutical Sciences, Nagasaki International University
- ↵* Corresponding author; email: muroth1{at}niu.ac.jp